Patent Assignment
Reel/Frame 052840/0433
Assignment of Assignor's Interest
Recorded: 2020-06-04
Pages: 6
Assignor
ALBANY MOLECULAR RESEARCH, INCORPORATED
Executed: 2020-04-24
Assignee
REATA PHARMACEUTICALS, INC.
2801 GATEWAY DRIVE, SUITE 150, IRVING, TEXAS, 75063
Covered Property
(1)
Co-Crystal Forms of a Novobiocin Analog and Proline
Patent:
10,717,755 →
Application:
16/265,256 →
Publication:
US 2019/0241599
PCT:
PCT/US2019/016304 ↗
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jun 4, 2020
From: JIANG, XIN; WALLING, JOHN ALLEN
To: REATA PHARMACEUTICALS, INC.
Reel/Frame 052839/0573 →
Assignment of Assignor's Interest
Jun 4, 2020
From: BEVILL, MELANIE J.; SEADEEK, CHRISTOPHER S.; SMIT, JARED P.
To: ALBANY MOLECULAR RESEARCH, INCORPORATED
Reel/Frame 052840/0616 →
Patent Security Agreement
May 18, 2023
From: REATA PHARMACEUTICALS HOLDINGS, LLC; REATA PHARMACEUTICALS GLOBAL, INC.; REATA PHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 063697/0461 →
Amended and Restated Patent Security Agreement
Jul 12, 2023
From: REATA PHARMACEUTICALS HOLDINGS, LLC; REATA PHARMACEUTICALS GLOBAL, INC.; REATA PHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 064264/0557 →
Release of Security Interest
Apr 9, 2025
From: BIOPHARMA CREDIT PLC
To: REATA PHARMACEUTICALS HOLDINGS, LLC; REATA PHARMACEUTICALS GLOBAL, INC.; REATA PHARMACEUTICALS, INC.
Reel/Frame 070793/0130 →
Release of Security Interest
Apr 9, 2025
From: BIOPHARMA CREDIT PLC
To: REATA PHARMACEUTICALS HOLDINGS, LLC; REATA PHARMACEUTICALS GLOBAL, INC.; REATA PHARMACEUTICALS, INC.
Reel/Frame 070793/0228 →